...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: ,Hong Kong exchange
Reply New Message
Back To Forum List View
,Hong Kong exchange
3
Polar one
Apr 26, 2018 06:10PM
Re: ,Hong Kong exchange
2
tada
Apr 27, 2018 12:09PM
Re: ,Hong Kong exchange
1
tada
Apr 27, 2018 12:16PM
Re: ,Hong Kong exchange
3
narmac
Apr 28, 2018 12:12PM
Re: ,Hong Kong exchange
2
narmac
Apr 29, 2018 08:59PM
Re: ,Hong Kong exchange
2
narmac
Apr 30, 2018 09:57AM
Re: ,Hong Kong exchange
3
narmac
Apr 30, 2018 10:42AM

KK2/narmac - I still believe it will be easier for management to get a better price for Zenith as a private company than as a public company. Every company can be valued not only on its balance sheet but on the potential of its assets as well.

All IMO

tada

3 Recommendations
Re: ,Hong Kong exchange

narmac
May 01, 2018 03:33PM
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply